Nintedanib: A novel therapeutic agent for pulmonary fibrosis
Main Authors: | Arpita Singh, Ajay Kumar Verma, Jyoti Bajpai, Ved Prakash, Surya Kant, Ankit Bhatia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | MAMC Journal of Medical Sciences |
Online Access: | http://www.mamcjms.in/article.asp?issn=2394-7438;year=2015;volume=1;issue=3;spage=172;epage=173;aulast=Singh |
Similar Items
-
Coexistence of leprosy and pulmonary tuberculosis: An uncommon entity
by: Ajay Kumar Verma, et al.
Published: (2015-01-01) -
A search for covert precipitating clinical parameters in frequent exacerbators of chronic obstructive pulmonary disease
by: Ankit Bhatia, et al.
Published: (2016-01-01) -
Indacaterol: A novel, Inhaled Beta-2 agonist for COPD
by: Ved Prakash, et al.
Published: (2015-01-01) -
Nintedanib in the treatment of idiopathic pulmonary fibrosis
by: Mariano E. Mazzei, et al.
Published: (2015-06-01) -
Is nintedanib effective for idiopathic pulmonary fibrosis?
by: Alejandro Jeldres
Published: (2017-06-01)